Blood pressure medications have been recalled several times in the past year. The recent recalls are caused by an elevated amount of nitrosamine, a compound which has been linked to cancer in animal studies.
Nitrosamines are common in food and water. While the risk of cancer is small, prolonged exposure to high levels of nitrosamines can increase the risk of cancer.
Two manufacturers have voluntarily recalled blood pressure medications. Pfizer has announced a recall of Accuretic, a medication used to treat hypertension. Another company, Lupin Pharmaceuticals, has recalled its Irbesartan tablets in 75-mg strength.
Both companies have notified their suppliers and distributors of the recalled lots. They plan to arrange for the return of recalled products. If you or someone you know is taking a recalled drug, contact the manufacturer or pharmacist for instructions.
Several other companies, including Hetero Labs, have also recalled medications in the last month. These products include Quinapril and Hydrochlorothiazide, which are used to treat hypertension.
Pfizer has recalled two generic formulations of the same blood pressure medication. Additionally, it is recalling all lots of Accuretic that were distributed in the United States. Its website provides more information about this recall.
Aurobindo Pharma USA, Inc., a subsidiary of the Indian pharmaceutical firm Aurobindo Pharma Ltd., has recalled a blood pressure medication that contains a potentially cancer-causing impurity. This recall includes two lots of the Quinapril-Hydrochlorothiazide, which is part of a family of drugs that are aimed at lowering blood pressure.